-+ 0.00%
-+ 0.00%
-+ 0.00%

China SXT Pharmaceuticals prices $12 million registered direct offering of 8,000,000 units at $1.50 each

PUBT·10/09/2026 21:01:01
Listen to the news
China SXT Pharmaceuticals prices $12 million registered direct offering of 8,000,000 units at $1.50 each
  • China SXT Pharmaceuticals priced a registered direct offering of 8,000,000 units at USD 1.50 per unit.
  • Gross proceeds expected at about USD 12 million, excluding warrant exercises; investors also received ordinary warrants.
  • Each warrant carries a USD 2.75 exercise price; exercisable immediately through one year from issuance.
  • Warrants include cashless exercise if no effective registration statement; “zero exercise price” option could lift issuable shares to 72,000,000.
  • Investors received a 30-day over-allotment option to buy up to an additional USD 12 million of securities on the same terms.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-108557), on October 09, 2026, and is solely responsible for the information contained therein.